Erik Procko

19PUBLICATIONS
51CO-AUTHORS
Environmental epidemiologyBiologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Nov 06, 2023
Sequence basis for selectivity of ephrin-B2 ligand for Eph receptors and pathogenic henipavirus G glycoproteins.

Krishna K Narayanan, Moushimi Amaya, Natalie Tsang

|May 12, 2023
A computationally designed ACE2 decoy has broad efficacy against SARS-CoV-2 omicron variants and related viruses in vitro and in vivo.

Brandon Havranek, Graeme Walker Lindsey, Yusuke Higuchi

|Feb 24, 2023
Xeno interactions between MHC-I proteins and molecular chaperones enable ligand exchange on a broad repertoire of HLA allotypes.

Yi Sun, Georgia F Papadaki, Christine A Devlin

|Sep 12, 2022
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS-CoV-2.

Lianghui Zhang, Krishna K Narayanan, Laura Cooper

|Jun 21, 2022
TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules.

Andrew C McShan, Christine A Devlin, Georgia F Papadaki

|Mar 21, 2022
A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions.

Magnus S Bauer, Sophia Gruber, Adina Hausch

Pageof 4

Frequent Collaborators

4 joint publications

Nikolaos G Sgourakis

4 joint publications

Christine A Devlin

2 joint publications

Jeremiah Dallas Heredia

2 joint publications

Asrar B Malik